Neuropsychological functioning in clinically referred patients with sarcoidosis: a preliminary investigation
Archives of Clinical Neuropsychology · 29.05.2026 · 41 (5)
DOI: 10.1093/arclin/acag042 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Archives of Clinical Neuropsychology, online erschienen am 04.06.2026. Verfasst von Rachel Galioto und 9 weiteren Autor:innen. Beteiligte Einrichtung: Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH, USA. Hauptthemen laut MEDLINE: Sarcoidosis, Central Nervous System Diseases, Cognition Disorders, Cognitive Dysfunction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Objective
Cognitive complaints are common among individuals with sarcoidosis, though little is known about objective cognitive performance in this group. This study examined performance on neuropsychological testing in patients with sarcoidosis who had subjective cognitive complaints, comparing performance between individuals with and without neurologic involvement (i.e., neurosarcoidosis [NS]).
Method
This is a retrospective, observational study of individuals with sarcoidosis who were referred for neuropsychological evaluation due to cognitive complaints. Mean test performances and rates of impairment on cognitive tests were examined and compared between individuals with NS and systemic sarcoidosis (SS).
Results
Thirty-seven individuals with sarcoidosis (n = 14 with NS) were included (Mage = 53.2 ± 10.0 years, Meducation = 14.5 ± 2.4 years, 83.8% White, 67.6% female), of whom 40.5% demonstrated cognitive impairment (CI; 2+ tests impaired). Impairments were most common on tests of verbal memory (24.2% immediate, 33.3% delayed), problem solving (25.8%), and verbal fluency (22.6%). All but one of the individuals with CI in the NS group had intracranial involvement. The main difference observed between NS and SS was worse performance on a measure of auditory attention/working memory, t(35) = −2.24, p = .03.
Conclusions
CI was observed in nearly half of patients with sarcoidosis who had subjective cognitive complaints. Additional research is needed to better understand the potential physiological underpinnings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH, USA.
- Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
- Department of Psychological Sciences, Kent State University, Kent, OH, USA.
- Department of Psychiatry, UT Southwestern Medical Center, Dallas, TX, USA.
- Department of Internal Medicine, Mount Sinai Hospital, New York, NY, USA.
- Department of Neurology, University of Washington, Seattle, WA, USA.
ORCID-Profile: Rachel Galioto
Zitieren
APA
Galioto, R., Lambe, J., Bhatia, U., Dhima, K., Galvani, E., Rhoads, T., Moss, B., Fienberg, L., Culver, D. A., & Kunchok, A. (2026). Neuropsychological functioning in clinically referred patients with sarcoidosis: a preliminary investigation. Archives of Clinical Neuropsychology, 41(5). https://doi.org/10.1093/arclin/acag042
Vancouver
Galioto R, Lambe J, Bhatia U, Dhima K, Galvani E, Rhoads T, et al. Neuropsychological functioning in clinically referred patients with sarcoidosis: a preliminary investigation. Archives of Clinical Neuropsychology. 2026;41(5). doi:10.1093/arclin/acag042
BibTeX
@article{Galioto2026,
author = {Galioto, Rachel and Lambe, Jeffrey and Bhatia, Urja and Dhima, Kaltra and Galvani, Eileen and Rhoads, Tasha and Moss, Brandon and Fienberg, Lilah and Culver, Daniel A and Kunchok, Amy},
title = {Neuropsychological functioning in clinically referred patients with sarcoidosis: a preliminary investigation},
journal = {Archives of Clinical Neuropsychology},
year = {2026},
volume = {41},
number = {5},
doi = {10.1093/arclin/acag042}
}
EUVIMED